BindingDB

null

SMILES [#6]-[#7]-[#6]-[#6]\[#6]=[#6]-1/c2ccccc2-[#6]-[#6]-c2ccccc-12

InChI Key InChIKey=PHVGLTMQBUFIQQ-UHFFFAOYSA-N

PDB links: 1 PDB ID matches this monomer.

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 112777

Cytochrome P450 2D26(Rattus norvegicus)
Vrije Universiteit

Curated by ChEMBL

BDBM112777(NORTRIPTYLINE | US8629135, SW-02)copy SMILEScopy InChI

IC50: 1.90E+3nMAssay Description:Inhibition of MAMC O-dealkylation mediated by rat Cytochrome P450 2D2 expressed in Saccharomyces cerevisiaeMore data for this Ligand-Target Pair

Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar

Purchase DrugBank MCE
KEGG PC cid PC sid PDB Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2K64JSDPubMed

Cytochrome P450 2D6(Homo sapiens (Human))
Vrije Universiteit

Curated by ChEMBL

BDBM112777(NORTRIPTYLINE | US8629135, SW-02)copy SMILEScopy InChI

IC50: 2.30E+3nMAssay Description:Inhibition of MAMC O-dealkylation mediated by human Cytochrome P450 2D6 expressed in human lymphoblastoid cell lineMore data for this Ligand-Target Pair

PDB
UniProtKB/SwissProt
GoogleScholar

Purchase DrugBank MCE
KEGG PC cid PC sid PDB Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2K64JSDPubMed

Cytochrome P450 2D3(Rattus norvegicus)
Vrije Universiteit

Curated by ChEMBL

BDBM112777(NORTRIPTYLINE | US8629135, SW-02)copy SMILEScopy InChI

IC50: 1.42E+4nMAssay Description:Inhibition of MAMC O-dealkylation mediated by rat Cytochrome P450 2D3 expressed in Saccharomyces cerevisiaeMore data for this Ligand-Target Pair

Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar

Purchase DrugBank MCE
KEGG PC cid PC sid PDB Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2K64JSDPubMed

Cytochrome P450 2D1(Rattus norvegicus)
Vrije Universiteit

Curated by ChEMBL

BDBM112777(NORTRIPTYLINE | US8629135, SW-02)copy SMILEScopy InChI

IC50: 2.04E+5nMAssay Description:Inhibition of MAMC O-dealkylation mediated by rat Cytochrome P450 2D1 expressed in Saccharomyces cerevisiaeMore data for this Ligand-Target Pair

Reactome pathway KEGG
UniProtKB/SwissProt
GoogleScholar

Purchase DrugBank MCE
KEGG PC cid PC sid PDB Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2K64JSDPubMed

Cytochrome P450 2D4(Rattus norvegicus)
Vrije Universiteit

Curated by ChEMBL

BDBM112777(NORTRIPTYLINE | US8629135, SW-02)copy SMILEScopy InChI

IC50: 1.93E+4nMAssay Description:Inhibition of MAMC O-dealkylation mediated by rat Cytochrome P450 2D4 expressed in Saccharomyces cerevisiaeMore data for this Ligand-Target Pair

UniProtKB/SwissProt
GoogleScholar

Purchase DrugBank MCE
KEGG PC cid PC sid PDB Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2K64JSDPubMed

Targets 37 ▿
- Sodium-dependent serotonin transporter 10
- Sodium-dependent noradrenaline transporter 6
- Histamine H1 receptor 4
- Sodium-dependent dopamine transporter 4
- 5-hydroxytryptamine receptor 6 3
- Proto-oncogene tyrosine-protein kinase receptor Ret 2
- Alpha-1A adrenergic receptor 2
- 5-hydroxytryptamine receptor 2C 2
- Norepinephrine transporter 2
- Sodium- and chloride-dependent betaine transporter 2
- Muscarinic acetylcholine receptor M2 2
- Sodium- and chloride-dependent GABA transporter 1 2
- Cytochrome P450 2D6 2
- Sodium- and chloride-dependent GABA transporter 3 2
- Bile salt export pump 2
- Sodium- and chloride-dependent GABA transporter 2 2
- Sigma non-opioid intracellular receptor 1 1
- Voltage-dependent N-type calcium channel subunit alpha-1B 1
- Muscarinic acetylcholine receptor M5 1
- Muscarinic acetylcholine receptor M4 1
- Muscarinic acetylcholine receptor M3 1
- Muscarinic acetylcholine receptor M1 1
- Beta-2 adrenergic receptor 1
- ATP-binding cassette sub-family C member 3 1
- Cytochrome P450 2D3 1
- ATP-binding cassette sub-family C member 4 1
- Cytochrome P450 2D4 1
- ATP-binding cassette sub-family C member 2 1
- Cytochrome P450 2D1 1
- D(2) dopamine receptor 1
- 5-hydroxytryptamine receptor 1A 1
- 5-hydroxytryptamine receptor 2A 1
- Cytochrome P450 2D26 1
- Sodium channel protein type 1/2/3 subunit alpha 1
- Cytochrome P450 2C8 1
- Alpha-2A adrenergic receptor 1
- Histamine H2 receptor 1
- ...
Publications 25 ▿
- Bioorg Med Chem 23: 2480-8 (2015) 8
- Psychopharmacology (Berl) 114: 559-65 (1994) 7
- Biol Psychiatry 55: 320-2 (2004) 6
- J Pharmacol Exp Ther 283: 1305-22 (1997) 6
- J Med Chem 46: 74-86 (2002) 5
- Biochem Pharmacol 45: 2352-4 (1993) 5
- Toxicol Sci 136: 216-41 (2013) 4
- J Pharmacol Exp Ther 226: 686-700 (1983) 3
- Psychopharmacology (Berl) 126: 234-40 (1996) 3
- Eur J Pharmacol 340: 249-58 (1997) 3
- J Med Chem 42: 3154-62 (1999) 3
- US Patent US8629135 (2014) 2
- Neuropharmacology 32: 737-43 (1993) 2
- J Med Chem 43: 1011-8 (2000) 1
- Mol Pharmacol 12: 568-80 (1976) 1
- J Med Chem 47: 5340-6 (2004) 1
- Curr Drug Metab 6: 413-54 (2005) 1
- Neuropharmacology 33: 275-317 (1994) 1
- Toxicol Sci 118: 485-500 (2010) 1
- J Med Chem 28: 381-8 (1985) 1
- Proc Natl Acad Sci U S A 75: 6290-4 (1978) 1
- J Pharm Pharmacol 38: 374-9 (1986) 1
- Brain Res 304: 1-7 (1984) 1
- Mol Pharmacol 43: 320-7 (1993) 1
- J Med Chem 55: 5704-19 (2012) 1
Institutions 19 ▿
- [Emory University] 12
- [Mayo Clinic Jacksonville] 10
- [University of Copenhagen] 8
- [Mayo Foundation] 6
- [Vrije Universiteit] 5
- [TBA, Amgen Inc] 4
- [TBA, Amgen Inc] 4
- [University of Turku, Universidad de Valencia, Pfizer Inc.,] 3
- [University of Turku, Universidad de Valencia, Pfizer Inc.,] 3
- [University of Turku, Universidad de Valencia, Pfizer Inc.,] 3
- [Queen's University at Kingston, Boots Pharmaceuticals] 2
- [Queen's University at Kingston, Boots Pharmaceuticals] 2
- [National Institute of Neurological Disorders and Stroke, University of Alberta, F. Hoffmann-La Roche Ltd., Virginia Commonwealth University, University of Leicester, University of North Carolina at Chapel Hill, Amgen Inc.] 1
- [National Institute of Neurological Disorders and Stroke, University of Alberta, F. Hoffmann-La Roche Ltd., Virginia Commonwealth University, University of Leicester, University of North Carolina at Chapel Hill, Amgen Inc.] 1
- [National Institute of Neurological Disorders and Stroke, University of Alberta, F. Hoffmann-La Roche Ltd., Virginia Commonwealth University, University of Leicester, University of North Carolina at Chapel Hill, Amgen Inc.] 1
- [National Institute of Neurological Disorders and Stroke, University of Alberta, F. Hoffmann-La Roche Ltd., Virginia Commonwealth University, University of Leicester, University of North Carolina at Chapel Hill, Amgen Inc.] 1
- [National Institute of Neurological Disorders and Stroke, University of Alberta, F. Hoffmann-La Roche Ltd., Virginia Commonwealth University, University of Leicester, University of North Carolina at Chapel Hill, Amgen Inc.] 1
- [National Institute of Neurological Disorders and Stroke, University of Alberta, F. Hoffmann-La Roche Ltd., Virginia Commonwealth University, University of Leicester, University of North Carolina at Chapel Hill, Amgen Inc.] 1
- [National Institute of Neurological Disorders and Stroke, University of Alberta, F. Hoffmann-La Roche Ltd., Virginia Commonwealth University, University of Leicester, University of North Carolina at Chapel Hill, Amgen Inc.] 1
Affinity: 0.040 to 3.9E+5 nM▿
- Ki 44
- IC50 26
- Affinity ≤ nM
Xtal structures: 0
Docked structures: 0
Catalog Cmpds: 1